GigaGen, Inc.

États‑Unis d’Amérique


 
Quantité totale PI 63
Rang # Quantité totale PI 21 470
Note d'activité PI 2,6/5.0    49
Rang # Activité PI 14 990
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

26 5
7 0
25 0
0
 
Dernier brevet 2024 - High-throughput analysis of anti...
Premier brevet 2011 - System and methods for massively...
Dernière marque 2023 - GIGA-564
Première marque 2020 - SURGE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention High-throughput analysis of antibody binding and specificity. The present disclosure provides a h...
Invention Hypogammaglobulinemia patient selection for immunoglobulin replacement therapy. The present discl...
2023 P/S Pharmaceutical and therapeutic preparations for the treatment of oncological diseases and disorde...
Invention Recombinant polyclonal proteins targeting zika and methods of use thereof. Provided herein are c...
Invention Recombinant polyclonal proteins targeting covid-19 and methods of use thereof. Provided herein a...
Invention System and method for massively parallel analysis for nucleic acids in single cells. Methods and...
2022 Invention Systems and methods for massively parallel combinatorial analysis of single cells. Provided herei...
Invention Recombinant fusion proteins and libraries from immune cell repertoires. Disclosed herein are met...
Invention Anti-ctla-4 binding proteins and methods of use thereof. Provided herein are antigen-binding prot...
2021 Invention System and methods for massively parallel analysis of nucleic acids in single cells. Methods and ...
Invention Recombinant polyclonal proteins targeting zika and methods of use thereof. Provided herein are co...
Invention Recombinant polyclonal proteins targeting covid-19 and methods of use thereof. Provided herein ar...
Invention Anti-ctla-4 binding proteins and methods of use thereof. Provided herein are antigen-binding pro...
Invention Bispecific antigen binding proteins targeting pd-l1 and tgf-β and methods of use. Provided herein...
Invention System and methods for massively parallel analysis of nucleic acids in single cells. Methods and...
Invention Cancer therapeutics comprising chemokine or its analog. The present disclosure provides a method ...
2020 Invention Recombinant fusion proteins and libraries from immune cell repertoires. Disclosed herein are meth...
Invention Recombinant polyclonal proteins and methods of use thereof. Provided herein are compositions com...
Invention Recombinant polyclonal proteins and methods of use thereof. Provided herein are compositions comp...
P/S pharmaceutical and therapeutic preparations for the treatment of immune deficiencies, autoimmune ...
P/S Medical and scientific research for the identification, preparation, and development of antibody ...
P/S Scientific research, namely, research and analysis services in the fields of artificial intellige...
Invention Anti-ox40 binding proteins and methods of use thereof. Provided herein are antigen-binding protei...
2019 Invention Anti-pd-1 binding proteins and methods of use thereof. Provided herein are antigen-binding prote...
Invention Anti-pd-l1 binding proteins and methods of use thereof. Provided herein are antigen-binding prot...
Invention Anti-pd-l1 binding proteins and methods of use thereof. Provided herein are antigen-binding prote...
Invention Anti-pd-1 binding proteins and methods of use thereof. Provided herein are antigen-binding protei...
Invention Anti-b7-h4 binding proteins and methods of use thereof. Provided herein are antigen-binding prote...
Invention Anti-b7-h3 binding proteins and methods of use thereof. Provided herein are antigen-binding prote...